Catalyst Wire Dossier Catalyst Wire Dossier

MelaB3 Serum

· Cosmetique Active International
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MelaB3 Serum, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions [NA]

See pricing